Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Cancer Res Treat ; 50(2): 335-344, 2018 Apr.
Article in English | MEDLINE | ID: mdl-28421723

ABSTRACT

PURPOSE: This study retrospectively evaluated the clinical outcomes and complications of proton beam therapy (PBT) in a single institution in Korea and quantitatively analyzed the change in tumor volume after PBT using magnetic resonance imaging (MRI). MATERIALS AND METHODS: Twenty-four treatment-naïve patients who underwent PBT for choroidal melanoma between 2009 and 2015 were reviewed. Dose fractionation was 60-70 cobalt gray equivalents over 5 fractions. Orbital MRIs were taken at baseline and 3, 6, and 12 months after PBT and annually thereafter. The tumor volume was reconstructed and evaluated by stacking the tumor boundary in each thin-sliced axial T1-weighted image using MIM software. RESULTS: The median follow-up duration was 36.5 months (range, 9 to 82 months). One patient had suspicious local progression and two patients had distant metastasis. The 3-year local progression-free survival, distant metastasis-free survival, and overall survival rates were 95.8%, 95.8%, and 100%,respectively. Five Common Terminology Criteria for Adverse Event ver. 4.03 grade 3-4 toxicities were observed in four patients (16.7%), including one with neovascular glaucoma. The mean tumor volume at the baseline MRI was 0.565±0.084 mL (range, 0.074 to 1.610 mL), and the ratios of the mean volume at 3, 6, and 12 months to that at baseline were 81.8%, 67.3%, and 60.4%, respectively. CONCLUSION: The local controlrate and complication profile after PBT in patientswith choroidal melanoma in Korea were comparable with those reported in a previous PBT series. The change in tumor volume after PBT exhibited a gradual regression pattern on MRI.


Subject(s)
Choroid Neoplasms/therapy , Melanoma/therapy , Proton Therapy/methods , Adult , Aged , Aged, 80 and over , Choroid Neoplasms/pathology , Female , Humans , Male , Melanoma/pathology , Middle Aged , Republic of Korea , Retrospective Studies , Treatment Outcome
3.
Graefes Arch Clin Exp Ophthalmol ; 253(12): 2111-9, 2015 Dec.
Article in English | MEDLINE | ID: mdl-25690978

ABSTRACT

PURPOSE: The purpose of this study was to describe the spectral domain optical coherence tomography (SD-OCT) characteristics of patients with retinal manifestations of mucopolysaccharidoses (MPSs) I, II, and IV A. DESIGN: The research was a prospective, observational study. METHODS: Fourteen consecutive patients with variants of MPS and 15 healthy subjects underwent ophthalmic assessments including fundus examinations and SD-OCT. RESULTS: The fundus examinations revealed that four patients (two MPS I and two MPS II) had pigmented retinopathy in both eyes. In addition, one MPS II patient had cystoid macular edema and two MPS II patients had abnormal disc morphology. SD-OCT revealed thinning of the parafoveal photoreceptor inner segment/outer segment (IS/OS; two MPS I and one MPS II) and perifoveal photoreceptor IS/OS (two MPS I and five MPS II). All MPS I and II patients exhibited thickening of the central foveal external limiting membrane (ELM). Fundus and SD-OCT findings were normal in MPS IV A and healthy subjects. The foveal ELM was significantly thicker in MPS I and II patients than in healthy subjects (P =0 .000 and P =0 .000, respectively). The foveal IS/OS was significantly thinner in MPS I, II, and IV A patients than in healthy subjects (P = 0.000, P = 0.000, and P = 0.030, respectively). The foveal retinal pigment epithelium layer was also thinner in MPS II patients than in healthy subjects (P = 0.007) CONCLUSIONS: In MPS, accumulation of glycosaminoglycans in retinal tissue induced retinal degeneration and pigmentary retinopathy. SD-OCT was a useful tool for detecting retinal pathology, particularly changes in ELM and IS/OS.


Subject(s)
Mucopolysaccharidosis II/diagnosis , Mucopolysaccharidosis IV/diagnosis , Mucopolysaccharidosis I/diagnosis , Retinitis Pigmentosa/diagnosis , Tomography, Optical Coherence , Adolescent , Child , Electroretinography , Evoked Potentials, Visual/physiology , Female , Humans , Male , Mucopolysaccharidosis I/physiopathology , Mucopolysaccharidosis II/physiopathology , Mucopolysaccharidosis IV/physiopathology , Prospective Studies , Retina/physiopathology , Retinitis Pigmentosa/physiopathology , Visual Field Tests , Visual Fields/physiology , Young Adult
5.
Korean J Ophthalmol ; 24(4): 249-51, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20714391

ABSTRACT

We here in report a case of bilateral endogenous endophthalmitis caused by Pantoea agglomerans (P. agglomerans) in a patient who had interstitial lung disease and was treated with oral corticosteroids. A 72-year-old man presented with decreased visual acuity in both eyes nine days after he received oral corticosteroids. He had marked uveitis, cataracts, and vitreous opacities. Cultures were taken of blood, aqueous humor, and vitreous. We initially suspected a fungal etiology and treated him with antifungal drugs; however, the intraocular disease progressed without improvement. Vitreous culture was positive for P. agglomerans. The patient underwent pars plana vitrectomy with cataract surgery bilaterally, followed by a 2-week course of antibiotics. The final visual acuity was 20/25 in the right eye and 20/200 in the left eye. This is the first report of bilateral endogenous endophthalmitis caused by P. agglomerans in Korea; it is also the first case reported outside of the United States.


Subject(s)
Endophthalmitis/microbiology , Enterobacteriaceae Infections/microbiology , Eye Infections, Bacterial/microbiology , Lung Diseases, Interstitial/complications , Pantoea/isolation & purification , Aged , Anti-Bacterial Agents/therapeutic use , Endophthalmitis/complications , Endophthalmitis/therapy , Enterobacteriaceae Infections/complications , Enterobacteriaceae Infections/therapy , Eye Infections, Bacterial/complications , Eye Infections, Bacterial/therapy , Follow-Up Studies , Humans , Male , Visual Acuity , Vitrectomy
SELECTION OF CITATIONS
SEARCH DETAIL
...